Cargando…

Seroprevalence and lethality by SARS-CoV-2 in indigenous populations of Latin America and the Caribbean: a systematic review

BACKGROUND: Latin America and the Caribbean (LAC) has presented some of the highest numbers of cases and deaths due to COVID-19 in the world. Even though indigenous communities represent 8% of the total population in this region, the impact of COVID-19 on this historically vulnerable population has...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernández-Vásquez, Akram, Chavez-Ecos, Fabian, Barrenechea-Pulache, Antonio, Comandé, Daniel, Bendezu-Quispe, Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684739/
https://www.ncbi.nlm.nih.gov/pubmed/35003919
http://dx.doi.org/10.7717/peerj.12552
_version_ 1784617681421336576
author Hernández-Vásquez, Akram
Chavez-Ecos, Fabian
Barrenechea-Pulache, Antonio
Comandé, Daniel
Bendezu-Quispe, Guido
author_facet Hernández-Vásquez, Akram
Chavez-Ecos, Fabian
Barrenechea-Pulache, Antonio
Comandé, Daniel
Bendezu-Quispe, Guido
author_sort Hernández-Vásquez, Akram
collection PubMed
description BACKGROUND: Latin America and the Caribbean (LAC) has presented some of the highest numbers of cases and deaths due to COVID-19 in the world. Even though indigenous communities represent 8% of the total population in this region, the impact of COVID-19 on this historically vulnerable population has only been briefly explored. Thus, this study aimed to estimate the seroprevalence and lethality attributable to SARS-CoV-2 in the indigenous population of LAC. METHODS: A systematic review was conducted utilizing multiple databases (registry PROSPERO: CRD42020207862). Studies published in English, Spanish or Portuguese were selected between December 1st, 2019, and April 14(th), 2021. The evaluation of the quality of the study was carried out utilizing the Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies. A qualitative synthesis of the data analyzed was conducted following the MOOSE and PRISMA declarations. RESULTS: Fifteen studies met the inclusion criteria. Eleven studies were carried out in a Brazilian population, three in a Mexican population, and one in a Colombian population. Four studies reported data about the seroprevalence of SARS-CoV-2 in indigenous populations of Brazil (range: 4.2–81.65%). Twelve studies reported lethality in indigenous people (eight in Brazil, three in Mexico, and one in Colombia). In Brazil, a lethality of 53.30% was described in a hospital setting and between 1.83% and 4.03% in community studies. In Mexico, the lethality of COVID-19 ranged between 16.5% and 19.9%. Meanwhile, in Colombia, a lethality of 3.41% was reported. Most studies were deemed to be of good quality. CONCLUSIONS: Despite COVID-19 affecting indigenous populations of LAC, there is limited evidence of the seroprevalence and lethality of the infection by SARS-CoV-2 in this population. Future investigations should ensure standardized methods that allow comparability among studies and ensure the precision of the results obtained.
format Online
Article
Text
id pubmed-8684739
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher PeerJ Inc.
record_format MEDLINE/PubMed
spelling pubmed-86847392022-01-06 Seroprevalence and lethality by SARS-CoV-2 in indigenous populations of Latin America and the Caribbean: a systematic review Hernández-Vásquez, Akram Chavez-Ecos, Fabian Barrenechea-Pulache, Antonio Comandé, Daniel Bendezu-Quispe, Guido PeerJ Epidemiology BACKGROUND: Latin America and the Caribbean (LAC) has presented some of the highest numbers of cases and deaths due to COVID-19 in the world. Even though indigenous communities represent 8% of the total population in this region, the impact of COVID-19 on this historically vulnerable population has only been briefly explored. Thus, this study aimed to estimate the seroprevalence and lethality attributable to SARS-CoV-2 in the indigenous population of LAC. METHODS: A systematic review was conducted utilizing multiple databases (registry PROSPERO: CRD42020207862). Studies published in English, Spanish or Portuguese were selected between December 1st, 2019, and April 14(th), 2021. The evaluation of the quality of the study was carried out utilizing the Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies. A qualitative synthesis of the data analyzed was conducted following the MOOSE and PRISMA declarations. RESULTS: Fifteen studies met the inclusion criteria. Eleven studies were carried out in a Brazilian population, three in a Mexican population, and one in a Colombian population. Four studies reported data about the seroprevalence of SARS-CoV-2 in indigenous populations of Brazil (range: 4.2–81.65%). Twelve studies reported lethality in indigenous people (eight in Brazil, three in Mexico, and one in Colombia). In Brazil, a lethality of 53.30% was described in a hospital setting and between 1.83% and 4.03% in community studies. In Mexico, the lethality of COVID-19 ranged between 16.5% and 19.9%. Meanwhile, in Colombia, a lethality of 3.41% was reported. Most studies were deemed to be of good quality. CONCLUSIONS: Despite COVID-19 affecting indigenous populations of LAC, there is limited evidence of the seroprevalence and lethality of the infection by SARS-CoV-2 in this population. Future investigations should ensure standardized methods that allow comparability among studies and ensure the precision of the results obtained. PeerJ Inc. 2021-12-16 /pmc/articles/PMC8684739/ /pubmed/35003919 http://dx.doi.org/10.7717/peerj.12552 Text en © 2021 Hernández-Vásquez et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Epidemiology
Hernández-Vásquez, Akram
Chavez-Ecos, Fabian
Barrenechea-Pulache, Antonio
Comandé, Daniel
Bendezu-Quispe, Guido
Seroprevalence and lethality by SARS-CoV-2 in indigenous populations of Latin America and the Caribbean: a systematic review
title Seroprevalence and lethality by SARS-CoV-2 in indigenous populations of Latin America and the Caribbean: a systematic review
title_full Seroprevalence and lethality by SARS-CoV-2 in indigenous populations of Latin America and the Caribbean: a systematic review
title_fullStr Seroprevalence and lethality by SARS-CoV-2 in indigenous populations of Latin America and the Caribbean: a systematic review
title_full_unstemmed Seroprevalence and lethality by SARS-CoV-2 in indigenous populations of Latin America and the Caribbean: a systematic review
title_short Seroprevalence and lethality by SARS-CoV-2 in indigenous populations of Latin America and the Caribbean: a systematic review
title_sort seroprevalence and lethality by sars-cov-2 in indigenous populations of latin america and the caribbean: a systematic review
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684739/
https://www.ncbi.nlm.nih.gov/pubmed/35003919
http://dx.doi.org/10.7717/peerj.12552
work_keys_str_mv AT hernandezvasquezakram seroprevalenceandlethalitybysarscov2inindigenouspopulationsoflatinamericaandthecaribbeanasystematicreview
AT chavezecosfabian seroprevalenceandlethalitybysarscov2inindigenouspopulationsoflatinamericaandthecaribbeanasystematicreview
AT barrenecheapulacheantonio seroprevalenceandlethalitybysarscov2inindigenouspopulationsoflatinamericaandthecaribbeanasystematicreview
AT comandedaniel seroprevalenceandlethalitybysarscov2inindigenouspopulationsoflatinamericaandthecaribbeanasystematicreview
AT bendezuquispeguido seroprevalenceandlethalitybysarscov2inindigenouspopulationsoflatinamericaandthecaribbeanasystematicreview